Clin2
NCT06982300Possibly a fitRecruiting

PET scan for advanced nasopharyngeal cancer

Nasopharyngeal Carcinoma (NPC)

Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.

This trial tests a special PET scan that can detect a receptor (SSTR2) on cancer cells to see if it can help guide treatment for people with nasopharyngeal cancer (a type of head and neck cancer). It may help doctors choose the best therapy for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
10 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have stage IB, II, III, or IVA nasopharyngeal cancer that is linked to the Epstein-Barr virus (a common virus).
  • You are scheduled to receive chemotherapy or chemoradiation (chemo plus radiation) as your first treatment.
  • You are 18 years old or older.
  • You can provide a sample of your tumor (either from a past biopsy or by having a new biopsy).
  • You have not had chemotherapy or radiation for nasopharyngeal cancer before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07137052Recruiting
Precise adaptive radiotherapy for nasopharyngeal cancer

This trial tests a more precise form of radiation therapy (adaptive radiotherapy) for nasopharyngeal cancer. It is designed for patients who have not yet had any treatment and whose cancer is limited to the head and neck area.

Xiamen
NCT07590024Recruiting· Phase 3
Personalized Cancer Treatment Guidance for Nasopharyngeal Cancer

This trial tests whether a special analysis of blood markers and imaging scans can help doctors choose the best combination of chemotherapy and radiation for nasopharyngeal cancer. The goal is to improve outcomes by tailoring treatment to each patient's specific cancer characteristics.

Beijing, Beijing Municipality
NCT06947759Not yet recruiting
PET/MRI scanning for advanced nasopharyngeal cancer

This trial uses a combined PET/MRI scan to see if it can better detect how far your cancer has spread at first diagnosis. It is for people with locally advanced nasopharyngeal cancer who have not had treatment yet.

Taichung
NCT07168785Not yet recruiting· Early Phase 1
PET imaging for advanced head and neck cancer

This trial uses a new imaging agent called [18F]-AraG to see how well it can show head and neck cancers before and after standard radiation therapy. If you have advanced cancer of the throat or voice box that can't be surgically removed, this scan may help doctors understand your cancer better.

Indianapolis, Indiana
NCT07659678Not yet recruiting· Phase 2
PET scan study for head and neck cancer patients

This trial uses a special PET scan to look at head and neck cancer cells before treatment. It may help doctors learn more about your cancer and decide if different treatments could work better for you.

St Louis, Missouri
NCT04499365Recruiting· Early Phase 1
PET scan for detecting different cancer types

This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.

Fuzhou, Fujian

Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.